Testing dotinurad for high uric acid in people with high blood pressure
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a medicine called dotinurad to see if it helps lower high uric acid levels in people who also have high blood pressure. It may be an option if you have not taken uric acid lowering drugs recently or have been off them for over 27 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older
- You have high uric acid, with a blood level over 7.0 mg/dL, and you have not used any uric acid lowering medication in the past 27 days, or you stopped taking such medication at least 27 days ago
- You have high blood pressure, and your blood pressure treatment (with or without medication) has been stable for at least 4 weeks
- You do not have active gout, kidney stones, or certain other medical conditions listed by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether burdock root extract can lower uric acid levels in people who have high uric acid but no symptoms of gout. It may help prevent future health problems related to high uric acid.
This trial tests a new drug called dotinurad for gout patients whose standard medications either don't work or cause side effects. Dotinurad works differently by helping your body get rid of uric acid (the substance that causes gout attacks), and the study will see if it safely lowers uric acid levels.
This study compares a new gout medicine called dotinurad to the common medicine allopurinol. It is for people who have had gout for at least a year, have had at least 2 gout attacks in the last year, and are already taking a stable dose of allopurinol but still have high uric acid levels.
This trial is testing a new gout medication, dotinurad, compared to the standard treatment allopurinol for people with tophaceous gout (gout that causes hard lumps). It aims to see if dotinurad is better at reducing uric acid and shrinking those lumps.
This study tests whether starting a new gout medicine called dotinurad at different times after a flare begins can help the flare go away faster. It may help people who have frequent gout attacks or certain health conditions.
This study tests a new medicine, NNC4004-0002, for people who have high uric acid levels but no gout symptoms. The goal is to see if it is safe and how well it works in healthy adults aged 35 to 75.
Hear when a new Hyperuricemia or Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.